(BXP) Boston Properties - Ratings and Ratios
Office Buildings, Workplaces, Commercial Real Estate, Gateway Markets, REIT
BXP EPS (Earnings per Share)
BXP Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.2% |
| Value at Risk 5%th | 49.3% |
| Relative Tail Risk | -0.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.18 |
| Alpha | -19.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.521 |
| Beta | 0.921 |
| Beta Downside | 0.987 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.56% |
| Mean DD | 15.94% |
| Median DD | 15.56% |
Description: BXP Boston Properties October 31, 2025
Boston Properties (NYSE:BXP) is the largest publicly traded REIT focused on premium office properties in the United States, operating primarily in six “gateway” markets-Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. As of June 30 2025, the company’s portfolio, including joint-venture assets, comprises roughly 53.7 million sq ft across 186 properties, with ten sites currently under construction or redevelopment.
Key performance indicators from the latest filings show an occupancy rate of about 93 % in Q2 2025 and FY 2025 funds-from-operations (FFO) of $1.12 per share, supporting a dividend yield near 5.2 %. The REIT’s net-debt-to-FFO leverage sits around 3.0×, reflecting a balance between growth-oriented capex (≈ $1.6 billion in 2025) and the need to preserve cash amid a higher-for-longer interest-rate environment. A primary sector driver remains the limited supply of Class-A office space in these high-density metros, which cushions rent growth despite broader hybrid-work trends that have softened demand in secondary markets.
For a deeper quantitative assessment, you may find ValueRay’s platform useful for benchmarking BXP’s metrics against peers.
BXP Stock Overview
| Market Cap in USD | 12,795m |
| Sub-Industry | Diversified REITs |
| IPO / Inception | 1997-06-18 |
| Return 12m vs S&P 500 | -18.3% |
| Analyst Rating | 3.55 of 5 |
BXP Dividends
| Dividend Yield | 5.15% |
| Yield on Cost 5y | 4.86% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 92.8% |
| Payout Ratio | 2.8% |
BXP Growth Ratios
| CAGR 3y | 6.03% |
| CAGR/Max DD Calmar Ratio | 0.15 |
| CAGR/Mean DD Pain Ratio | 0.38 |
| Current Volume | 808.5k |
| Average Volume | 1547.5k |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-200.4m TTM) > 0 and > 6% of Revenue (6% = 207.8m TTM) |
| FCFTA 25.0k (>2.0%) and ΔFCFTA 2.50mpp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.27% (prev 8.36%; Δ 37.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 25.0k (>3.0%) and CFO 1.23b > Net Income -200.4m (YES >=105%, WARN >=100%) |
| Net Debt (16.77b) to EBITDA (1.60b) ratio: 10.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (158.3m) change vs 12m ago 0.08% (target <= -2.0% for YES) |
| Gross Margin 53.91% (prev 41.84%; Δ 12.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 26.24% (prev 12.79%; Δ 13.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.39 (EBITDA TTM 1.60b / Interest Expense TTM 496.6m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 56.59
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 4.17% = 2.09 |
| 3. FCF Margin 35.60% = 7.50 |
| 4. Debt/Equity 3.54 = -1.52 |
| 5. Debt/Ebitda 10.47 = -2.50 |
| 6. ROIC - WACC (= -3.49)% = -4.36 |
| 7. RoE -3.82% = -0.64 |
| 8. Rev. Trend 97.58% = 7.32 |
| 9. EPS Trend -6.09% = -0.30 |
What is the price of BXP shares?
Over the past week, the price has changed by -2.38%, over one month by +0.16%, over three months by +9.34% and over the past year by -6.40%.
Is Boston Properties a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BXP is around 67.92 USD . This means that BXP is currently overvalued and has a potential downside of -3.85%.
Is BXP a buy, sell or hold?
- Strong Buy: 6
- Buy: 3
- Hold: 11
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the BXP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 79.8 | 13% |
| Analysts Target Price | 79.8 | 13% |
| ValueRay Target Price | 72.7 | 2.9% |
BXP Fundamental Data Overview November 11, 2025
P/E Forward = 39.0625
P/S = 3.7358
P/B = 2.2741
P/EG = 0.3716
Beta = 1.011
Revenue TTM = 3.46b USD
EBIT TTM = 689.9m USD
EBITDA TTM = 1.60b USD
Long Term Debt = 15.72b USD (from longTermDebt, last fiscal year)
Short Term Debt = 750.0m USD (from shortTermDebt, last quarter)
Debt = 17.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.77b USD (from netDebt column, last quarter)
Enterprise Value = 29.57b USD (12.80b + Debt 17.71b - CCE 938.7m)
Interest Coverage Ratio = 1.39 (Ebit TTM 689.9m / Interest Expense TTM 496.6m)
FCF Yield = 4.17% (FCF TTM 1.23b / Enterprise Value 29.57b)
FCF Margin = 35.60% (FCF TTM 1.23b / Revenue TTM 3.46b)
Net Margin = -5.79% (Net Income TTM -200.4m / Revenue TTM 3.46b)
Gross Margin = 53.91% ((Revenue TTM 3.46b - Cost of Revenue TTM 1.60b) / Revenue TTM)
Gross Margin QoQ = 33.30% (prev 60.69%)
Tobins Q-Ratio = 599.7k (set to none) (Enterprise Value 29.57b / Total Assets 49.3k)
Interest Expense / Debt = 0.92% (Interest Expense 162.8m / Debt 17.71b)
Taxrate = 83.05% (69.9m / 84.2m)
NOPAT = 117.0m (EBIT 689.9m * (1 - 83.05%))
Current Ratio = 2.08 (Total Current Assets 3.08b / Total Current Liabilities 1.48b)
Debt / Equity = 3.54 (Debt 17.71b / totalStockholderEquity, last quarter 5.01b)
Debt / EBITDA = 10.47 (Net Debt 16.77b / EBITDA 1.60b)
Debt / FCF = 13.60 (Net Debt 16.77b / FCF TTM 1.23b)
Total Stockholder Equity = 5.25b (last 4 quarters mean from totalStockholderEquity)
RoA = -406.5k% (out of range, set to none)
RoE = -3.82% (Net Income TTM -200.4m / Total Stockholder Equity 5.25b)
RoCE = 3.29% (EBIT 689.9m / Capital Employed (Equity 5.25b + L.T.Debt 15.72b))
RoIC = 0.55% (NOPAT 117.0m / Invested Capital 21.23b)
WACC = 4.04% (E(12.80b)/V(30.51b) * Re(9.41%) + D(17.71b)/V(30.51b) * Rd(0.92%) * (1-Tc(0.83)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.34%
[DCF Debug] Terminal Value 74.50% ; FCFE base≈1.14b ; Y1≈1.21b ; Y5≈1.46b
Fair Price DCF = 127.0 (DCF Value 20.11b / Shares Outstanding 158.4m; 5y FCF grow 7.34% → 3.0% )
EPS Correlation: -6.09 | EPS CAGR: -30.76% | SUE: -1.48 | # QB: 0
Revenue Correlation: 97.58 | Revenue CAGR: 3.64% | SUE: 1.90 | # QB: 15
Additional Sources for BXP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle